The role and importance of auxiliary tests in differential diagnosis in patients with mildly high basal 17-OH-progesterone levels in the evaluation of hirsutism
Yıl: 2020 Cilt: 50 Sayı: 8 Sayfa Aralığı: 1976 - 1982 Metin Dili: İngilizce DOI: 10.3906/sag-2004-263 İndeks Tarihi: 22-07-2022
The role and importance of auxiliary tests in differential diagnosis in patients with mildly high basal 17-OH-progesterone levels in the evaluation of hirsutism
Öz: Background/aim: In the differential diagnosis of hirsutism, early follicular basal 17-OH-progesterone levels sometimes overlap with the
diagnosis of late onset congenital adrenal hyperplasia (LOCAH) and other causes of hyperandrogenism. This study aims to investigate
the role of some common tests and clinical findings in differential diagnosis in such cases.
Materials and methods: One hundred seventy-five female patients with hirsutism and mildly high initial 17-OH-progesterone levels
(2-10 ng/mL) were included in the study. The cases were divided into three groups according to their diagnosis: LOCAH (n = 16, mean
age = 26.1 ± 6.9), polycystic ovary syndrome (PCOS) (n = 122, mean age = 23.9 ± 5.1), and intracranial hypertension (IH) (n = 37, mean
age = 25.2 ± 7.3). Clinical signs and symptoms, such as menstrual irregularity and hirsutism score, and hormone levels including total
testosterone and dehydroepiandrosterone sulfate (DHEAS), were compared between the groups.
Results: There was no difference between the groups with PCOS, LOCAH, and IH for total testosterone level results (P = 0.461). The
DHEAS level was higher in the PCOS group than in the LOCAH group (449.6 ± 151.14 vs. 360.31 ± 152.40, P = 0.044). While there
was no difference between the PCOS and LOCAH groups in terms of menstrual irregularity (P = 0.316), the hirsutism score for IH was
significantly lower than those of PCOS and LOCAH (9.2 vs. 12.2 and 11.1, respectively; P < 0.001). Basal 17-OH-progesterone levels
were higher in the LOCAH group than in the other groups (P = 0.016).
Conclusion: While DHEAS level was lower in LOCAH than in PCOS, it was not different from that in IH. While the severity of
hirsutism was higher in LOCAH than in IH, it was not different from that in PCOS. Menstrual irregularity was similar between PCOS
and LOCAH. According to these results, although the auxiliary tests and clinical findings for the diagnosis of LOCAH contribute to the
clinical interpretation, they are not superior to the 17-OH-progesterone level for diagnosis.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- 1. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR et al. Prevalence of the Polycystic Ovary Syndrome in unselected black and white women of the southeastern United States: a prospective study 1. The Journal of Clinical Endocrinology & Metabolism 1998; 83(9):3078-3082.doi: 10.1210/jcem.83.9.5090
- 2. Lipton MG, Sherr L, Elford J, Rustin MHA, Clayton WJ. Women living with facial hair: the psychological and behavioral burden. Journal of Psychosomatic Research 2006; 61(2):161- 168.doi: 10.1016/j.jpsychores.2006.01.016
- 3. Hahn S, Janssen OE, Tan S, Pleger K, Mann K et al. Clinical and psychological correlates of quality-of-life in polycystic ovary syndrome. European Journal of Endocrinology 2005; 153(6):853-860.doi: 10.1530/eje.1.02024
- 4. Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. The Journal of Clinical Endocrinology and Metabolism 1961; 21:1440-1447.doi: 10.1210/jcem-21-11- 1440
- 5. Rosenfield RL. Clinical practice. Hirsutism. The New England Journal of Medicine 2005; 353(24):2578-2588.doi: 10.1056/ NEJMcp033496
- 6. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Human Reproduction 2004; 19: 41-47.doi: 10.1093/ humrep/deh098
- 7. Azziz R, Sanchez LA, Knochenhauer ES, Moran C, Lazenby J et al. Androgen excess in women: experience with over 1000 consecutive patients. Journal of Clinical Endocrinology and Metabolism 2004; 89: 453-462.doi: 10.1210/jc.2003-031122
- 8. Carmina E, Rosato F, Jannì A, Rizzo M, Longo RA. Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. The Journal of Clinical Endocrinology and Metabolism 2006; 91(1):2-6.doi: 10.1210/jc.2005-1457
- 9. Azziz R, Dewailly D, Owerbach D. Clinical review 56: Nonclassic adrenal hyperplasia: current concepts. The Journal of Clinical Endocrinology and Metabolism 1994; 78(4):810- 815.doi: 10.1210/jcem.78.4.8157702
- 10. White PC, Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocrine Reviews 2000; 21(3):245-291.doi: 10.1210/edrv.21.3.0398
- 11. New MI, Lorenzen F, Lerner AJ, Kohn B, Oberfield SE et al. Genotyping steroid 21-hydroxylase deficiency: hormonal reference data. The Journal of Clinical Endocrinology and Metabolism 1983; 57(2):320-326.doi: 10.1210/jcem-57-2-320
- 12. Speiser PW, White PC. Congenital adrenal hyperplasia. The New England Journal of Medicine 2003; 349(8):776-788.doi: 10.1056/NEJMra021561
- 13. Wilson RC, Mercado AB, Cheng KC, New MI. Steroid 21-hydroxylase deficiency: genotype may not predict phenotype. The Journal of Clinical Endocrinology and Metabolism 1995; 80(8): 2322-2329.doi: 10.1210/jcem.80.8.7629224
- 14. Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Murad MH et al. Diagnosis and treatment of polycystic ovary syndrome: An endocrine society clinical practice guideline. The Journal of Clinical Endocrinology and Metabolism 2013; 98(12):4565-4592.doi: 10.1210/jc.2013-2350
- 15. Kamel N, Tonyukuk V, Emral R, Corapçioǧlu D, Baştemir M et al. The prevalence of late onset congenital adrenal hyperplasia in hirsute women from Central Anatolia. Endocrine Journal 2003; 50(6):815-823.doi: 10.1507/endocrj.50.815
- 16. Lobo RA, Goebelsmann U. Adult manifestation of congenital adrenal hyperplasia due to incomplete 21-hydroxylase deficiency mimicking polycystic ovarian disease. American Journal of Obstetrics and Gynecology 1980; 138(6):720-726. doi: 10.1016/0002-9378(80)90095-2
- 17. New MI. Nonclassical congenital adrenal hyperplasia and the polycystic ovarian syndrome. Annals of the New York Academy of Sciences 1993; 687(1):193-205.doi: 10.1111/ j.1749-6632.1993.tb43866.x
- 18. Speiser PW, Dupont B, Rubinstein P, Piazza A, Kastelan A et al. High frequency of nonclassical steroid 21-hydroxylase deficiency. American Journal of Human Genetics 1985; 37(4):650-667.
- 19. The VL, Lachance Y, Labrie C, Leblanc G, Thomas JL et al. Full length cdna structure and deduced amino acid sequence of human 3β-hydroxy-5-ene steroid dehydrogenase. Molecular Endocrinology 1989; 3(8):1310-1312.doi: 10.1210/mend-3-8- 1310
- 20. Peter M, Dubuis JM, Sippell WG. Disorders of the aldosterone synthase and steroid 11β-hydroxylase deficiencies. Hormone Research 1999; 51:211-222.doi: 10.1159/000023374
- 21. Meikle AW. The phenotype of hirsute women: a comparison of polycystic ovary syndrome and 21-hydroxylase-deficient nonclassic adrenal hyperplasia. Yearbook of Endocrinology 2011; 2011:283-284.doi: 10.1016/s0084-3741(10)79621-9
- 22. Moore A, Magee F, Cunningham S, Culliton M, Mckenna TJ. Adrenal abnormalities in idiopathic hirsutism. Clinical Endocrinology 1983;18(4):391-399. doi: 10.1111/j.1365- 2265.1983.tb00584.x
- 23. Goodarzi MO, Carmina E, Azziz R. DHEA, DHEAS and PCOS. Journal of Steroid Biochemistry and Molecular Biology 2015; 145: 213-225.doi: 10.1016/j.jsbmb.2014.06.003
- 24. Pall M, Azziz R, Beires J, Pignatelli D. The phenotype of hirsute women: a comparison of polycystic ovary syndrome and 21-hydroxylase-deficient nonclassic adrenal hyperplasia. Fertility and Sterility 2010;94(2):684-689.doi: 10.1016/j. fertnstert.2009.06.025
- 25. Dharia S, Slane A, Jian M, Conner M, Conley AJ et al. Effects of aging on cytochrome B5 expression in the human adrenal gland. Journal of Clinical Endocrinology and Metabolism 2005; 90(7):4357-4361.doi: 10.1210/jc.2005-0017
| APA | Demirci T, Cengiz H, Varım C, ÇETİN S (2020). The role and importance of auxiliary tests in differential diagnosis in patients with mildly high basal 17-OH-progesterone levels in the evaluation of hirsutism. , 1976 - 1982. 10.3906/sag-2004-263 |
| Chicago | Demirci Taner,Cengiz Hasret,Varım Ceyhun,ÇETİN SEDAT The role and importance of auxiliary tests in differential diagnosis in patients with mildly high basal 17-OH-progesterone levels in the evaluation of hirsutism. (2020): 1976 - 1982. 10.3906/sag-2004-263 |
| MLA | Demirci Taner,Cengiz Hasret,Varım Ceyhun,ÇETİN SEDAT The role and importance of auxiliary tests in differential diagnosis in patients with mildly high basal 17-OH-progesterone levels in the evaluation of hirsutism. , 2020, ss.1976 - 1982. 10.3906/sag-2004-263 |
| AMA | Demirci T,Cengiz H,Varım C,ÇETİN S The role and importance of auxiliary tests in differential diagnosis in patients with mildly high basal 17-OH-progesterone levels in the evaluation of hirsutism. . 2020; 1976 - 1982. 10.3906/sag-2004-263 |
| Vancouver | Demirci T,Cengiz H,Varım C,ÇETİN S The role and importance of auxiliary tests in differential diagnosis in patients with mildly high basal 17-OH-progesterone levels in the evaluation of hirsutism. . 2020; 1976 - 1982. 10.3906/sag-2004-263 |
| IEEE | Demirci T,Cengiz H,Varım C,ÇETİN S "The role and importance of auxiliary tests in differential diagnosis in patients with mildly high basal 17-OH-progesterone levels in the evaluation of hirsutism." , ss.1976 - 1982, 2020. 10.3906/sag-2004-263 |
| ISNAD | Demirci, Taner vd. "The role and importance of auxiliary tests in differential diagnosis in patients with mildly high basal 17-OH-progesterone levels in the evaluation of hirsutism". (2020), 1976-1982. https://doi.org/10.3906/sag-2004-263 |
| APA | Demirci T, Cengiz H, Varım C, ÇETİN S (2020). The role and importance of auxiliary tests in differential diagnosis in patients with mildly high basal 17-OH-progesterone levels in the evaluation of hirsutism. Turkish Journal of Medical Sciences, 50(8), 1976 - 1982. 10.3906/sag-2004-263 |
| Chicago | Demirci Taner,Cengiz Hasret,Varım Ceyhun,ÇETİN SEDAT The role and importance of auxiliary tests in differential diagnosis in patients with mildly high basal 17-OH-progesterone levels in the evaluation of hirsutism. Turkish Journal of Medical Sciences 50, no.8 (2020): 1976 - 1982. 10.3906/sag-2004-263 |
| MLA | Demirci Taner,Cengiz Hasret,Varım Ceyhun,ÇETİN SEDAT The role and importance of auxiliary tests in differential diagnosis in patients with mildly high basal 17-OH-progesterone levels in the evaluation of hirsutism. Turkish Journal of Medical Sciences, vol.50, no.8, 2020, ss.1976 - 1982. 10.3906/sag-2004-263 |
| AMA | Demirci T,Cengiz H,Varım C,ÇETİN S The role and importance of auxiliary tests in differential diagnosis in patients with mildly high basal 17-OH-progesterone levels in the evaluation of hirsutism. Turkish Journal of Medical Sciences. 2020; 50(8): 1976 - 1982. 10.3906/sag-2004-263 |
| Vancouver | Demirci T,Cengiz H,Varım C,ÇETİN S The role and importance of auxiliary tests in differential diagnosis in patients with mildly high basal 17-OH-progesterone levels in the evaluation of hirsutism. Turkish Journal of Medical Sciences. 2020; 50(8): 1976 - 1982. 10.3906/sag-2004-263 |
| IEEE | Demirci T,Cengiz H,Varım C,ÇETİN S "The role and importance of auxiliary tests in differential diagnosis in patients with mildly high basal 17-OH-progesterone levels in the evaluation of hirsutism." Turkish Journal of Medical Sciences, 50, ss.1976 - 1982, 2020. 10.3906/sag-2004-263 |
| ISNAD | Demirci, Taner vd. "The role and importance of auxiliary tests in differential diagnosis in patients with mildly high basal 17-OH-progesterone levels in the evaluation of hirsutism". Turkish Journal of Medical Sciences 50/8 (2020), 1976-1982. https://doi.org/10.3906/sag-2004-263 |
